The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection

Aging Cell

Volumn 11, Issue 5, 2012, Pages 912-915

  Bartlett, David B ^a   Firth, Charlotte M ^a   Phillips, Anna C ^a   Moss, Paul ^a   Baylis, Daniel ^b   Syddall, Holly ^b   Sayer, Avan A ^b   Cooper, Cyrus ^b   Lord, Janet M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Aging; Cytokines; Inflammation

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SERODIAGNOSIS;

AGE FACTORS; AGED; C-REACTIVE PROTEIN; CYTOKINES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; PROTOZOAN PROTEINS; RISK FACTORS;

CYTOMEGALOVIRUS; HERPESVIRIDAE;

EID: 84866436856     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2012.00849.x     Document Type: Article

References (20)

1. Abu-Taha M, Rius C, Hermenegildo C, Noguera I, Cerda-Nicolas JM, Issekutz AC, Jose PJ, Cortijo J, Morcillo EJ, Sanz MJ (2009) Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J. Immunol. 183, 1393-1402.
2. Baylis D, Bartlett DB, Syddall HE, Ntani G, Gale CR, Cooper C, Lord JM, Sayer AA (2012) Immune-endocrine biomarkers as predictors of frailty and mortality: a ten year longitudinal study in community dwelling older people. AGE. doi:10.1007/s11357-012-9396-8.
3. Derhovanessian E, Maier AB, Beck R, Jahn G, Hahnel K, Slagboom PE, de Craen AJM, Westendorp RGJ, Pawelec G (2010) Hallmark features of immunosenescence are absent in familial longevity. J. Immunol. 185, 4618-4624.
4. Ford ES (2002) Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology 13, 561-568.
5. Forsythe LK, Wallace JM, Livingstone MB (2008) Obesity and inflammation: the effects of weight loss. Nutr. Res. Rev. 21, 117-133.
6. Franceschi C, Monti D, Sansoni P, Cossarizza A (1995) The immunology of exceptional individuals: the lesson of centenarians. Immunol. Today 16, 12-16.
7. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244-254.
8. Hummel M, Abecassis MM (2002) A model for reactivation of CMV from latency. J. Clin. Virol. 25(Suppl 2), S123-S136.
9. Jenny NS, Tracy RP, Ogg MS, Luong LA, Kuller LH, Arnold AM, Sharrett AR, Humphries SE (2002) In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler. Thromb. Vasc Biol. 22, 2066-2071.
10. Khan N, Shariff N, Cobbold M, Ainsworth JA, Bruton R, Sinclair AJ, Nayak L, Moss PAH (2002) Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol 169, 1984-1992.
11. Libby P, Okamoto Y, Rocha VZ, Folco E (2010) Inflammation in atherosclerosis: transition from theory to practice. Circ. J. 74, 213-220.
12. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, Franceschi C, Caruso C (2002) Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun. 3, 30-33.
13. Maggio M, Basaria S, Ble A, Lauretani F, Bandinelli S, Ceda GP, Valenti G, Ling SM, Ferrucci L (2006) Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J. Clin. Endocrinol. Metab. 91, 345-347.
14. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, Carella C, Giugliano D, Varricchio M, D'Onofrio F (1998) Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am. J. Physiol. 275, E294-E299.
15. Pawelec G, Larbi A, Derhovanessian E (2010) Senescence of the Human Immune System. J. Comp. Pathol. 142(Suppl 1), S39-S44.
16. Roberts ET, Haan MN, Dowd JB, Aiello AE (2010) Cytomegalovirus antibody levels, inflammation, and mortality among elderly latinos over 9 years of follow-up. Am. J. Epidemiol. 172, 363-371.
17. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE (2011) Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS ONE 6, e16103.
18. Syddall HE, Simmonds SJ, Martin HJ, Watson C, Dennison EM, Cooper C, Sayer AA (2010) Cohort profile: The Hertfordshire Ageing Study (HAS). Int. J. Epidemiol. 39, 36-43.
19. Wikby A, Johansson B, Ferguson F, Olsson J (1994) Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp. Gerontol. 29, 531-541.
20. Wikby A, Nilsson B-O, Forsey R, Thompson J, Strindhall J, Löfgren S, Emerudh J, Pawelec G, Ferguson F, Johansson B (2006) The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech. Ageing Dev. 127, 695-704.